fda-1
carmendorin / iStockphoto.com
7 December 2018Big Pharma

FDA to focus on data in new ‘top strategic priority’

The US Food and Drug Administration (FDA) has announced a new strategy for the use of “real-world evidence” (RWE) and “real-world data” (RWD) to improve its regulation of new drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
11 October 2018   The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.
Americas
3 January 2018   The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today.